Interleukin‐4 inhibits the hypothalamic appetite control by modulating the insulin ‐AKT and JAK‐STAT signaling in leptin mutant mice
Environmental Toxicology · 2024-07 · 39 (7) · 3980-3990
DOI: 10.1002/tox.24264 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Toxicology, online erschienen am 10.04.2024. Verfasst von Shu-Mei Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Internal Medicine, Tri-Service General Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Hypothalamus, Interleukin-4, Signal Transduction, Leptin. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Science and Technology Council, Tri-Service General Hospital, Taipei, Veterans General Hospitals and University System of Taiwan Joint Research Program.
Abstract (Originalsprache)
Our previous research identified interleukin‐4 (IL‐4) as a key regulator of glucose/lipid metabolism, circulatory leptin levels, and insulin action, suggesting its potential as a therapeutic target for obesity and related complications. This study aimed to further elucidate the role of IL‐4 in regulating hypothalamic appetite‐controlling neuropeptides using leptin dysfunctional Leptin 145E/145E mice as the experimental model. IL‐4 significantly reduces body weight, food intake, and serum glucose levels. Our data demonstrated that IL‐4 exhibits multiple functions in regulating hypothalamic appetite control, including downregulating orexigenic agouti‐related peptide and neuropeptide Y levels, promoting expression of anorexigenic proopiomelanocortin, alleviating microenvironmental hypothalamic inflammation, enhancing leptin and insulin pathway, and attenuating insulin resistance. Furthermore, IL‐4 promotes uncoupling protein 1 expression of white adipose tissue (WAT), suggesting its role in triggering WAT‐beige switch. In summary, this study uncovers novel function of IL‐4 in mediating food‐intake behaviors and metabolic efficiency by regulating hypothalamic appetite‐control and WAT browning activities. These findings support the therapeutic potential of targeting hypothalamic inflammation and reducing adiposity through IL‐4 intervention for tackling the pandemic increasing prevalence of obesity and associated metabolic disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Department of Internal Medicine, Tri-Service General Hospital, Taipei, Taiwan.
- Institute of Brain Science of National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Research Assistant Center, Tainan Municipal Hospital (Managed by Show Chwan Medical Care Corporation), Tainan, Taiwan.
- Section of Psychosomatic Medicine, Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
- Department of Medical Technology, Jenteh Junior College of Medicine, Nursing and Management, Miaoli, Taiwan.
ORCID-Profile: Ching-Ping Yang
Förderung
- National Science and Technology Council
- Tri-Service General Hospital, Taipei
- Veterans General Hospitals and University System of Taiwan Joint Research Program
- TSGH
Zitieren
APA
Chen, S. M., Hsiao, C. W., Chen, Y. J., Hong, C. J., Lin, J. C., Yang, C. P., & Chang, Y. H. (2024). Interleukin‐4 inhibits the hypothalamic appetite control by modulating the insulin ‐AKT and JAK‐STAT signaling in leptin mutant mice. Environmental Toxicology, 39(7), 3980-3990. https://doi.org/10.1002/tox.24264
Vancouver
Chen SM, Hsiao CW, Chen YJ, Hong CJ, Lin JC, Yang CP, et al. Interleukin‐4 inhibits the hypothalamic appetite control by modulating the insulin ‐AKT and JAK‐STAT signaling in leptin mutant mice. Environmental Toxicology. 2024;39(7):3980-3990. doi:10.1002/tox.24264
BibTeX
@article{Chen2024,
author = {Chen, Shu-Mei and Hsiao, Chiao-Wan and Chen, Yen-Ju and Hong, Chen-Jee and Lin, Jung-Chun and Yang, Ching-Ping and Chang, Yih-Hsin},
title = {Interleukin‐4 inhibits the hypothalamic appetite control by modulating the insulin ‐AKT and JAK‐STAT signaling in leptin mutant mice},
journal = {Environmental Toxicology},
year = {2024},
volume = {39},
number = {7},
pages = {3980--3990},
doi = {10.1002/tox.24264}
}
EUVIMED